EP247: From Quality Measures to Medicare Advantage (Maybe for All) and Price Gouging, With John Gorman, CEO and Chairman of Nightingale Partners
October 17, 2019
247
34:28

EP247: From Quality Measures to Medicare Advantage (Maybe for All) and Price Gouging, With John Gorman, CEO and Chairman of Nightingale Partners

In this health care podcast, I speak with John Gorman, who is a government-sponsored health programs guru. He’s also the founder of a newly minted organization called Nightingale that (spoiler alert) we discuss toward the end of our conversation. I just want to interject right here that I, for one—but I’m sure John would agree—do not believe that Medicare Advantage (MA) is, as is, perfectly terrific and devoid of problems.

There are, of course, well-known issues with coding, the whole exaggerated diagnoses for higher reimbursements thing … then there’s the whole potentially wasteful quotas payments and the restrictive networks of doctors cited issues. We don’t get into these during our conversation, focusing instead on comparing MA to FFS (fee-for-service) Medicare.

From there, we get into advice for independent physicians in rural hospitals and then we wind up at price gouging by nonprofit hospitals. John’s points are insightful as always, and I guarantee he will give you a lot to think about.

You can learn more and connect with John on LinkedIn.

John Gorman is the founder and former executive chairman at Gorman Health Group (GHG). For 22 years he led the development of the industry’s leading consulting practice and several entrepreneurial ventures in government health programs. John’s work focuses on Medicare Advantage, Medicaid, and Accountable Care Act strategy, governance, and social determinants of health. John considers himself a defender and fixer of health insurance coverage, especially Medicare, Medicaid, and subsidized individuals served by health plans. He has strong opinions and relies on evidence and sound policy. Prior to founding GHG in 1996, he was appointed by President Clinton as the first assistant to the director of the Health Care Financing Administration’s (now Centers for Medicare and Medicaid Services) Office of Managed Care.

After leaving GHG in July 2018, John founded and currently serves as the CEO and chairman of Nightingale Partners, an organization dedicated to helping payers and providers make an impact on social influences that prevent patients from achieving healthy, happy lives. Nightingale Partners is a qualified Opportunity Zone investment firm focused on social determinants of health.

John continues to speak regularly at about two dozen industry conferences across the country each year and is regularly quoted in the trade press and national media. He serves on the board of directors of Henry Ford Health System’s Health Alliance Plan in his birthplace of Detroit and serves as a senior adviser on Medicare Advantage and Medicaid to Premier Inc., the hospital purchasing cooperative. John serves on the editorial advisory boards of several industry publications, including Bloomberg Government.


01:37 The quality measures being used to assess value.
04:00 “Half of the rating is attributable to the member experience.”
04:29 Are the ways that FFS and Medicare Advantage value-based care measures are weighted legitimate?
07:59 Insurance carrier profitability.
08:33 Medicare for all to Medicare Advantage for all—how John sees this morphing into the future.
11:07 Is insurance profitability at the expense of the rest of the country?
13:47 “A more rigorous antitrust approach to hospital mergers would certainly help.”
15:10 “Get bigger and get more sophisticated in … the value you bring to the table.”
16:49 “There’s always strength in numbers.”
20:35 EP202 with Frazer Buntin.
23:28 “If you’re not adapting, you’re dying in this environment if you’re a hospital.”
24:37 John’s advice to rural hospitals.
27:44 EP219 with Arshad Rahim.
28:27 What Nightingale is and what they do.

You can learn more and connect with John on LinkedIn.

healthcare,health,gorman health group,measures,quality,nightingale partners,medicare,
|
|

Episode Support Provided By

Special Thanks to Our 2026 Sustaining Monthly Donors

Marilyn Bartlett, Kimberly Carleson, Dylan Yahn, Benjamin Light, Matt McQuide, Ann Kempski, Spencer Allen, Scott Tromanhauser, Steven Elkins, Matthew Bunte, Lori Smith, Dr. Scott Conard, Vivian Ho and Casey Cormier

Recent Episodes

EP536: Operationalizing the Architecture of Primary Care Patient Experience, With Rebecca Andrews, MD
Relentless Health ValueNovember 04, 2026
536
37:5134.64 MB

EP536: Operationalizing the Architecture of Primary Care Patient Experience, With Rebecca Andrews, MD

Listen On Your Favorite App Stacey: If you are a plan sponsor thinking about, for example, primary care as a way to optimize healthcare spend, do know that any given plan sponsor will really only get maximum possible benefit from an investment in primary care, advanced primary care, when and only wh...

EP535: When Patient Experience Means Parking and Pianos, Plan Sponsors Pay for Hotels, Not Outcomes—What to Measure Instead, With Robyn Leone
Relentless Health ValueOctober 28, 2026
535
37:1834.15 MB

EP535: When Patient Experience Means Parking and Pianos, Plan Sponsors Pay for Hotels, Not Outcomes—What to Measure Instead, With Robyn Leone

LIsten on Your Favorite App On episode 532 a few weeks ago, Chris Klomp from HHS was talking about ER (emergency room) usage as a signal, not just a statistic. If too many folks show up in the ER, consider this a signal that there's something missing. It means a patient who doesn't have access to pr...

EP534: The One Question to Test if a TPA Is Actually Independent, With Kimberly Carleson
Relentless Health ValueOctober 21, 202608:538.13 MB

EP534: The One Question to Test if a TPA Is Actually Independent, With Kimberly Carleson

Listen On Your Favorite App Here's a question I have heard more than once: What is a practical, speedy way to assess whether a TPA (third-party administrator) is truly independent and willing to protect the plan's interests, this plan sponsor's interests, versus being captive to, for example, networ...

EP533: Level Funding Is Self-funding: 5 Avoidable Contract Risks, With Frank Pennachio
Relentless Health ValueOctober 14, 2026
533
37:1334.07 MB

EP533: Level Funding Is Self-funding: 5 Avoidable Contract Risks, With Frank Pennachio

Hello, all you Relentless Tribe members. Thanks for hanging with me today to talk about a bunch of things. One of them being what exactly are level-funded plans, and what are the upsides, and then what are the risks? Because here's the thing. I was talking to an employer the other day, an employer w...

EP532: Why Avoidable ER Visits Aren't the Real Cost Problem: Revisiting Our 2016 Interview With HHS Nominee Chris Klomp
Relentless Health ValueOctober 07, 2026
532
37:2034.17 MB

EP532: Why Avoidable ER Visits Aren't the Real Cost Problem: Revisiting Our 2016 Interview With HHS Nominee Chris Klomp

Listen on Your Favorite App Today we are dipping into the archives for an essential replay from 2016, one decade ago, featuring Chris Klomp back when he served as CEO of a company called Collective Medical. With the nomination of Chris Klomp to serve as deputy secretary of the Department of Health a...

EP531: Slaying the Three-Headed Monster of Health Plan Networks, With Evan Anderson
Relentless Health ValueSeptember 30, 2026
531
38:0634.88 MB

EP531: Slaying the Three-Headed Monster of Health Plan Networks, With Evan Anderson

Listen on Your Favorite App Today, Evan Anderson and I are talking about carrier networks, how they started, how it's going. Because irrespective of whatever the plan was at the very beginning, any given network, especially talking about the big status quo networks, has evolved into what I'll call a...

EP530: A Wildly Underappreciated Point: Overpaying for Infusions Means Overpaying for Stop-Loss Coverage, With Jake Velie and Keith Hartman, RPh
Relentless Health ValueSeptember 23, 2026
530
37:4534.56 MB

EP530: A Wildly Underappreciated Point: Overpaying for Infusions Means Overpaying for Stop-Loss Coverage, With Jake Velie and Keith Hartman, RPh

Listen on Your Favorite App Hello, all you Relentless Tribe members. Thanks for hanging with me this week. When a self-insured plan sponsor sees an infusion claim hit their high-cost case report, and a lot of these infusions are really expensive, so many of them hit the high-cost claim report. For a...

Listen and Follow

Sponsored by Aventria Health Group
©2026 BD Bridges LLC. All Rights Reserved.